97 related articles for article (PubMed ID: 30787091)
21. Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.
Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Karlstad Ø; Juzeniene A; Ghiasvand R; Larsen IK; Green AC; Veierød MB; Robsahm TE
Clin Epidemiol; 2020; 12():1389-1401. PubMed ID: 33376408
[TBL] [Abstract][Full Text] [Related]
22. Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.
Berge LAM; Andreassen BK; Stenehjem JS; Heir T; Furu K; Juzeniene A; Roscher I; Larsen IK; Green AC; Veierød MB; Robsahm TE
Clin Epidemiol; 2020; 12():193-202. PubMed ID: 32110111
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for the development of malignant melanoma--I: Review of case-control studies.
Evans RD; Kopf AW; Lew RA; Rigel DS; Bart RS; Friedman RJ; Rivers JK
J Dermatol Surg Oncol; 1988 Apr; 14(4):393-408. PubMed ID: 3280634
[TBL] [Abstract][Full Text] [Related]
24. Etiology and epidemiology of melanoma and skin neoplasms.
Osterlind A
Curr Opin Oncol; 1991 Apr; 3(2):355-9. PubMed ID: 2069996
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.
Berge LAM; Andreassen BK; Stenehjem JS; Larsen IK; Furu K; Juzeniene A; Roscher I; Heir T; Green A; Veierød MB; Robsahm TE
BMJ Open; 2019 Feb; 9(2):e025246. PubMed ID: 30787091
[TBL] [Abstract][Full Text] [Related]
26. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
Stenehjem JS; Grimsrud TK; Rees JR; Vos L; Babigumira R; Veierød MB; Robsahm TE
BMJ Open; 2017 Jun; 7(6):e014829. PubMed ID: 28637727
[TBL] [Abstract][Full Text] [Related]
27. Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.
Andreassen BK; Støer NC; Martinsen JI; Ursin G; Weiderpass E; Thoresen GH; Debernard KB; Karlstad Ø; Pottegard A; Friis S
BMJ Open; 2019 Apr; 9(4):e028504. PubMed ID: 30962244
[TBL] [Abstract][Full Text] [Related]
28. Injury Prevention and long-term Outcomes following Trauma-the IPOT project: a protocol for prospective nationwide registry-based studies in Norway.
Stenehjem JS; Røise O; Nordseth T; Clausen T; Natvig B; O Skurtveit S; Eken T; Kristiansen T; Gran JM; Rosseland LA
BMJ Open; 2021 May; 11(5):e046954. PubMed ID: 34006552
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.
Robsahm TE; Bergva G; Hestvik UE; Møller B
Melanoma Res; 2013 Feb; 23(1):70-8. PubMed ID: 23222548
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.
Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
Age Ageing; 2013 Jul; 42(4):514-20. PubMed ID: 23438446
[TBL] [Abstract][Full Text] [Related]
31. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma.
Pottegård A; Pedersen SA; Schmidt SAJ; Hölmich LR; Friis S; Gaist D
JAMA Intern Med; 2018 Aug; 178(8):1120-1122. PubMed ID: 29813157
[TBL] [Abstract][Full Text] [Related]
32. Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012.
Arnold M; de Vries E; Whiteman DC; Jemal A; Bray F; Parkin DM; Soerjomataram I
Int J Cancer; 2018 Sep; 143(6):1305-1314. PubMed ID: 29659012
[TBL] [Abstract][Full Text] [Related]
33. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.
Gandini S; Palli D; Spadola G; Bendinelli B; Cocorocchio E; Stanganelli I; Miligi L; Masala G; Caini S
Crit Rev Oncol Hematol; 2018 Feb; 122():1-9. PubMed ID: 29458778
[TBL] [Abstract][Full Text] [Related]
34. Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
Pottegård A; Friis S; Stürmer T; Hallas J; Bahmanyar S
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):451-459. PubMed ID: 29265740
[TBL] [Abstract][Full Text] [Related]
35. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
36. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
